US pharmaceutical firms ‘fear change’ and need guidance on assessing safe excipient supply to become more like their European counterparts, says a senior IPEC expert.
All4NutraNo products in the cart.
All4NutraStartseite » News » Managing excipient supply needs risk guidance, not ‘fear’ says expert
By Fiona BARRY, 19-Mar-2014
US pharmaceutical firms ‘fear change’ and need guidance on assessing safe excipient supply to become more like their European counterparts, says a senior IPEC expert.
Copyright: PharmaExcipients AG